14RS SB236
LRC Seal

SB236

14RS

WWW Version

The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.


SB 236 (BR 1217) - D. Harper Angel, W. Blevins Jr., P. Clark

     AN ACT relating to the Kentucky clinical health trials fund and making an appropriation therefor.
     Amend KRS 304.17B-021 to create the Kentucky clinical health trials fund; create a new section of KRS Chapter 304.17B establishing the Governance Board of the Kentucky Clinical Health Trials Project; amend KRS 304.17A-250 to change reference from "Kentucky Access" to "Kentucky clinical health trials fund"; amend KRS 304.17B-001 to change the definition of "Assessment process" to refer to the assessment funding of the Kentucky clinical health trials fund; amend KRS 304.17B-007 to remove the requirement for reimbursement of GAP losses; repeal KRS 304.17B-023; direct 50% disbursement of first year funds of the Kentucky clinical health trials fund to the University of Louisville for study of the benefits of medical marijuana; stagger initial board terms for the Governance Board of the Kentucky Clinical Health Trials Project; EFFECTIVE January 1, 2015.

     Mar 6-introduced in Senate
     Mar 11-to Banking & Insurance (S)


Legislature Home Page | Record Front Page